Serum procalcitonin is a sensitive marker for septic shock and mortality in secondary peritonitis

Anaesthesiology Intensive Therapy

Volumn 46, Issue 4, 2014, Pages 262-273

  Pupelis, Guntars ^a   Drozdova, Nadezda ^a   Mukans, Maksims ^a   Malbrain, Manu Lng ^b  

^a RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^b Stuivenberg General Hospital   (Belgium)

Author keywords

Mortality; Procalcitonin; Secondary peritonitis; Septic shock

Indexed keywords

C REACTIVE PROTEIN; LACTIC ACID; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MORTALITY RISK; NEUTROPHIL COUNT; ORGAN DYSFUNCTION SCORE; PERITONITIS; SEPTIC SHOCK; SURGICAL INTENSIVE CARE UNIT; BLOOD; COMPLICATION; INTENSIVE CARE UNIT; METABOLISM; MIDDLE AGED; NEUTROPHIL; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK; SENSITIVITY AND SPECIFICITY; SEPSIS; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; INTENSIVE CARE UNITS; LACTIC ACID; MALE; MIDDLE AGED; NEUTROPHILS; PERITONITIS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; RISK; SENSITIVITY AND SPECIFICITY; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

EID: 84986879737     PISSN: 16425758     EISSN: 17312531     Source Type: Journal    
DOI: 10.5603/AIT.2014.0043     Document Type: Article

References (35)

1. Hotchkiss RS, Karl IE: The Pathophysiology and Treatment of Sepsis. N Engl J Med 2003; 348: 2
2. Angus DC, Linde-Zwirble WT, Lidicker J et al.: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310
3. Thomas LG: Secretory Immunoglobulins. N Engl J Med 1972; 287: 500-506
4. Pierrakos C, Vincent JL: Sepsis biomarkers: A review. Crit Care 2010; 14: R15
5. Calandra T, Cohen J: The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit. Crit Care Med 2005; 33: 1538-1548
6. Crandall M, Michael A: Evaluation of the abdomen in the critically ill patient: opening the black box. Curr Opin Crit Care 2006; 12: 333-339
7. Finfer S, Bellomo R, Lipman J et al.: Adult population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004; 30: 589-596
8. Padkin A, Goldfrad C, Brady AR et al.: Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31: 2332-2338
9. Lagu T, Rothberg MB, Shieh MS et al.: Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012; 40: 754-761
10. Kumar A, Roberts D, Wood KE et al.: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596
11. Hakansson A, Molin G: Gut microbiota and inflammation. Nutrients 2011; 3: 637-682
12. Wacha H, Linder MM, Feldmann U et al.: Mannheims peritonitis index-prediction of risk of death from peritonitis. Theoretical Surg 1987; 1: 169-177
13. Gullo A, Bianco N, Berlot G: Management of severe sepsis and septic shock: challenges and recommendations. Crit Care Clin 2006; 22: 489-501
14. Weighardt H, Heidecke C-D, Emmanuilidis K et al.: Sepsis after major visceral surgery is associated with sustained and interferon-gamma-resistant defects of monocyte cytokine production. Surgery 2000; 127: 309-315
15. Linder A, Christensson B, Herwald H et al.: Heparin-binding protein: An early marker of circulatory failure in sepsis. Clin Infect Dis 2009; 49: 1044-1050
16. Hotchkiss RS, Swanson PE, Freeman BD et al.: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27: 1230-1251
17. Hotchkiss RS, Tinsley KW, Swanson PE et al.: Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001; 166: 6952-6963
18. Karlsson S, Heikkinen M, Pettilä V et al.: Predictive value of procalcitonin decrease in patients with severe sepsis: A prospective observational study. Crit Care 2010; 14: R205
19. Rivers E, Nguyen B, Havstad S et al.: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377
20. Sankoff JD, Goyal M, Gaieski DF et al.: Validation of the Mortality in Emergency Department Sepsis (MEDS) score in patients with the systemic inflammatory response syndrome (SIRS). Crit Care Med 2008; 36: 421-426
21. Dulhunty JM, Lipman J, Finfer S: Does severe non-infectious SIRS differ from severe sepsis Intensive Care Med 2008; 34: 1654-1661
22. Dönser MW, Takala J, Ulmer H et al.: Arterial blood pressure during early sepsis and outcome. Intensive Care Med 2009; 35: 1225-1233
23. Ospina-Tascon G, Neves AP, Occhipinti G et al.: Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med 2010; 36: 949-955
24. Trzeciak S, McCoy JV, Philip Dellinger R et al.: Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008; 34: 2010-2017
25. Rivers EP, Kruse JA, Jacobsen G et al.: The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock Crit Care Med 2007; 35: 2016-2024
26. van Ruler O, Kiewiet JJ, Boer KR et al.: Failure of available scoring systems to predict ongoing infection in patients with Abdominal sepsis after their initial emergency laparotomy. BMC Surg 2011; 11: 38
27. Borgel D, Bornstain C, Reitsma PH et al.: A comparative study of the protein c pathway in septic and nonseptic patients with organ failure Am J Respir Crit Care Med 2007; 176: 878-885
28. Toussaint S, Gerlach H: Activated protein C for sepsis. N Engl J Med 2009; 361: 2646-2652
29. Ali NA, O'Brien JM Jr, Dungan K et al.: Glucose variability and mortality in patients with sepsis. Crit Care Med 2008; 36: 2316-2321
30. Brunkhorst FM, Engel C, Bloos F et al.: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139 31.
31. Dellinger RP, Carlet JM, Masur H et al.: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858-873
32. Perel A: Bench-To-bedside review: The initial hemodynamic resuscitation of the septic patient according to Surviving Sepsis Campaign guidelines-does one size fit all? Crit Care 2008; 12: 223
33. Jensen JU, Heslet L, Jensen TH et al.: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34: 2596-2602
34. Nobre V, Harbarth S, Graf JD et al.: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: A randomized . Am J Respir Crit Care Med 2008; 177: 498-505
35. Novotny AR, Emmanuel K, Hueser N et al.: Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis. Surgery 2009; 145: 20-26